Engineers Gate Manager’s Exagen XGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$172K Sell
37,000
-49,231
-57% -$185K ﹤0.01% 1989
2026
Q1
$259K Buy
86,231
+23,267
+37% +$90K ﹤0.01% 1786
2025
Q4
$383K Buy
62,964
+21,780
+53% +$198K ﹤0.01% 1498
2025
Q3
$453K Buy
+41,184
New +$365K 0.01% 1564

Other funds holding XGN

Engineers Gate Manager's XGN Position: Q2 2026 in Review

Engineers Gate Manager reduced its Exagen (XGN) stake by 57% in Q2 2026, selling an estimated $185K and leaving 37,000 shares worth $172K. The position accounts for ﹤0.01% of the portfolio, ranked #1989.

Engineers Gate Manager first reported a position in XGN in Q3 2025 and has held it in 4 quarters since. The position peaked at $453K in Q3 2025. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

  • Engineers Gate Manager held 37,000 shares of Exagen worth $172K as of Q2 2026.
  • Engineers Gate Manager sold 49,231 Exagen shares in Q2 2026, an estimated $185K.
  • Exagen made up ﹤0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1989 holding.
  • Engineers Gate Manager first reported a position in Exagen in Q3 2025 and has held it in 4 quarters since.
  • Engineers Gate Manager's Exagen position peaked at $453K in Q3 2025.
  • 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.